Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma

[21] Roy A(2006)Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver BMC Cancer 6 89-847

[22] Roy B(2005)Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors Int J Cancer 115 684-134

[23] Lee JS(2003)Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma Oncogene 22 1866-384

[24] Fackler MJ(1998)Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 844-109

[25] Teo WW(2007)Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer Cancer Genomics Proteomics 4 121-1458

[26] Lee JH(2006)Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling Semin Liver Dis 26 373-137

[27] Choi C(2007)The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node-negative breast cancer: a tissue microarray study Int J Surg Pathol 15 98-2026

[28] Park MH(2008)RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County J Gastroenterol Hepatol 23 1448-616

[29] Pallarés J(2002)Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma Clin Cancer Res 8 131-6193

[30] Velasco A(2007)Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in serum Cancer 110 2019-93

[21] Roy A(2006)Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver BMC Cancer 6 89-847

[22] Roy B(2005)Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors Int J Cancer 115 684-134

[23] Lee JS(2003)Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma Oncogene 22 1866-384

[24] Fackler MJ(1998)Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 844-109

[25] Teo WW(2007)Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer Cancer Genomics Proteomics 4 121-1458

[26] Lee JH(2006)Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling Semin Liver Dis 26 373-137

[27] Choi C(2007)The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node-negative breast cancer: a tissue microarray study Int J Surg Pathol 15 98-2026

[28] Park MH(2008)RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County J Gastroenterol Hepatol 23 1448-616

[29] Pallarés J(2002)Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma Clin Cancer Res 8 131-6193

[30] Velasco A(2007)Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in serum Cancer 110 2019-93